Caspase-1 Contributes toChlamydia trachomatis-Induced Upper Urogenital Tract Inflammatory Pathologies without Affecting the Course of Infection
Open Access
- 1 February 2008
- journal article
- research article
- Published by American Society for Microbiology in Infection and Immunity
- Vol. 76 (2), 515-522
- https://doi.org/10.1128/iai.01064-07
Abstract
Chlamydia trachomatis infection induces inflammatory pathologies in the upper genital tract, potentially leading to ectopic pregnancy and infertility in the affected women. Caspase-1 is required for processing and release of the inflammatory cytokines interleukin-1β (IL-1β), IL-18, and possibly IL-33. In the present study, we evaluated the role of caspase-1 in chlamydial infection and pathogenesis. Although chlamydial infection induced caspase-1 activation and processing of IL-1β, mice competent and mice deficient in caspase-1 experienced similar courses of chlamydial infection in their urogenital tracts, suggesting that Chlamydia-activated caspase-1 did not play a significant role in resolution of chlamydial infection. However, when genital tract tissue pathologies were examined, the caspase-1-deficient mice displayed much reduced inflammatory damage. The reduction in inflammation was most obvious in the fallopian tube tissue. These observations demonstrated that although caspase-1 is not required for controlling chlamydial infection, caspase-1-mediated responses can exacerbate the Chlamydia-induced inflammatory pathologies in the upper genital tract, suggesting that the host caspase-1 may be targeted for selectively attenuating chlamydial pathogenicity without affecting the host defense against chlamydial infection.Keywords
This publication has 83 references indexed in Scilit:
- Intranasal Vaccination with a Secreted Chlamydial Protein Enhances Resolution of GenitalChlamydia muridarumInfection, Protects against Oviduct Pathology, and Is Highly Dependent upon Endogenous Gamma Interferon ProductionInfection and Immunity, 2007
- IL-33, the IL-1-like cytokine ligand for ST2 receptor, is a chromatin-associated nuclear factorin vivoProceedings of the National Academy of Sciences, 2007
- Inhibition of Matrix Metalloproteinases Protects Mice from Ascending Infection and Chronic Disease Manifestations Resulting from UrogenitalChlamydia muridarumInfectionInfection and Immunity, 2006
- Treatment of Chlamydia trachomatis with a small molecule inhibitor of the Yersinia type III secretion system disrupts progression of the chlamydial developmental cycleMolecular Microbiology, 2006
- The Hypothetical Protein CT813 Is Localized in theChlamydia trachomatisInclusion Membrane and Is Immunogenic in Women Urogenitally Infected withC. trachomatisInfection and Immunity, 2006
- Inhibition of Proteolytic Activity of a Chlamydial Proteasome/Protease-Like Activity Factor by Antibodies from Humans Infected with Chlamydia trachomatisInfection and Immunity, 2005
- Production of a Proteolytically Active Protein, Chlamydial Protease/Proteasome-Like Activity Factor, by Five Different Chlamydia SpeciesInfection and Immunity, 2005
- Human Antibody Responses to a Chlamydia-Secreted Protease FactorInfection and Immunity, 2004
- Role for Inducible Nitric Oxide Synthase in Protection from ChronicChlamydia trachomatisUrogenital Disease in Mice and Its Regulation by Oxygen Free RadicalsInfection and Immunity, 2001
- Pathogenesis of Chlamydia induced pelvic inflammatory diseaseSexually Transmitted Infections, 1999